Psychiatry Prior Authorization Automation for Mental & Behavioral Health

The Unique Landscape of Psychiatry Prior Authorization

Psychiatric and substance use disorder (SUD) services present distinct PA complexities. Unlike many medical-surgical procedures, behavioral health often involves highly time-sensitive admission decisions and continuous concurrent review for inpatient and residential stays. Furthermore, state-level parity laws and SUD treatment funding can introduce significant variability in coverage [mhpaea].

High-Volume PA Categories in Psychiatry

• Inpatient psychiatric admission and continued stay, often requiring ASAM criteria for SUD or InterQual/MCG for general psychiatry.
• Partial hospitalization (PHP) and intensive outpatient (IOP) levels of care.
• Residential treatment for SUD and eating disorders, frequently among the most heavily PA-managed services.
• Specialty psychiatric medications, including long-acting injectables (e.g., paliperidone palmitate), esketamine (Spravato), and brexanolone (Zulresso).
• Electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS), typically requiring documentation of prior medication trials.
• Ketamine and esketamine clinics, with varying payer policies and FDA REMS requirements for esketamine.
• Specialty drugs for tardive dyskinesia (e.g., valbenazine/Ingrezza, deutetrabenazine/Austedo).

Critical Documentation Requirements for Psychiatric Services

• **For inpatient/residential admissions:** DSM-5-TR diagnosis, severity scales (e.g., PHQ-9, GAD-7), safety risk assessment, and documentation of prior level-of-care trials [apa-guidelines].
• **For ASAM levels:** Comprehensive documentation across the six ASAM dimensions, demonstrating fidelity to placement criteria [asam-criteria].
• **For TMS:** Evidence of failed antidepressant trials (often 2-4 adequate dose/duration trials) per payer specifics.
• **For specialty injectables:** Diagnosis confirmation, prior oral-medication trial where applicable, and REMS documentation for restricted-dispensing drugs like esketamine.

Common Reasons for Psychiatry PA Denials

• **ASAM level mismatch:** Denial of a higher level of care (e.g., residential) when ASAM dimensions support a lower level, or vice versa [asam-criteria].
• **Step therapy:** Insufficient documentation of prior antidepressant trials for TMS or oral medication trials for specialty injectables.
• **Concurrent review denials:** Continued inpatient stay denied when severity criteria are no longer met.
• **Parity-act violations:** Payer criteria appearing more restrictive than comparable medical-surgical benefits, potentially challenging under MHPAEA [mhpaea].
• **Out-of-network treatment:** Particularly prevalent for residential SUD treatment where in-network options are limited.

Klivira's Solution for Psychiatry Prior Authorization Automation

Klivira's platform is engineered to address the specific demands of psychiatric PA. Our system incorporates ASAM-criteria-aware level-of-care logic and automates concurrent review workflows for inpatient and residential continued stays. We also provide automation for TMS step-therapy documentation and flag potential parity issues when payer criteria appear overly restrictive compared to medical-surgical benefits [mhpaea].

Seamless Integration with EMRs and Payer Portals

Klivira integrates directly with your existing EMR system, pulling necessary clinical documentation for psychiatric services and pushing authorization statuses back into patient records. Our platform connects to a vast network of payer portals, utilizing X12 278, ePA, and NCPDP SCRIPT standards to streamline submission and tracking across all mental and behavioral health services.